Form 4: BIODESIX Director Schuler Buys $1M+ in Stock

Jack W. Schuler, a Director and 10% Owner of BIODESIX INC, acquired 142,045 shares of common stock for $7.04 per share, totaling approximately $1 million, under a pre-arranged trading plan.

Summary

• Jack W. Schuler, a Director and 10% Owner of BIODESIX INC (BDSX), acquired 142,045 shares of common stock.
• The transaction is scheduled for September 19, 2025, at a price of $7.04 per share.
• The total value of the acquisition is approximately $1,000,086.80.
• The acquisition was made indirectly through the Jack W. Schuler Living Trust.
• Following this transaction, Jack W. Schuler will beneficially own 1,380,745 shares through the Jack W. Schuler Living Trust and 750,000 shares through the Jack W. Schuler 2025 GRAT, for a total of 2,130,745 shares.
• The transaction was made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.

Sentiment

Score: 8

Explanation: The significant insider purchase by a director and 10% owner, especially under a pre-arranged plan, indicates strong confidence in the company's future prospects and valuation.

Positives

• A Director and 10% Owner, Jack W. Schuler, increased his stake in BIODESIX INC, signaling confidence in the company's future.
• The acquisition of 142,045 shares at $7.04 per share represents a significant investment of over $1 million by an insider.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-planned investment strategy.

Future Outlook

NA

Industry Context

This insider purchase by a significant shareholder and director of BIODESIX INC may be viewed by the market as a positive signal, potentially indicating management's belief in the company's future prospects, especially within the diagnostics or biotechnology sector where such signals can be influential.

Related Party Transactions

• Jack W. Schuler's beneficial ownership includes shares held indirectly through the Jack W. Schuler Living Trust and the Jack W. Schuler 2025 GRAT, where he serves as sole trustee.

Stakeholder Impact

• Shareholders may interpret the insider purchase as a positive indicator of future company performance and management's belief in the stock's value.
• The transaction could enhance investor confidence in BIODESIX INC.

Key Dates

Recommendation

The substantial purchase of company stock by a Director and 10% Owner, Jack W. Schuler, at a price of $7.04 per share, signals strong insider confidence. Such a significant investment, particularly when executed under a Rule 10b5-1 plan, suggests that a key insider believes the stock is undervalued or has significant upside potential. This action typically serves as a positive catalyst for investors, indicating a favorable outlook from those closest to the company's operations and strategy.

Keywords

BIODESIX INC, BDSX, Jack W. Schuler, Insider Trading, Stock Purchase, Director, 10% Owner, SEC Form 4, Equity Acquisition, Rule 10b5-1